Medindia

X

Scientists Team Up to Treat Pancreatic Cancer by Identifying Clinical Biomarkers

by Julia Samuel on  April 8, 2015 at 10:24 AM Cancer News   - G J E 4
Berg, a small Boston-based biotech firm, teams up with a group of hospitals and research teams to discover and treat pancreatic cancer by means of a clinical biomarker.
Scientists Team Up to Treat Pancreatic Cancer by Identifying Clinical Biomarkers
Scientists Team Up to Treat Pancreatic Cancer by Identifying Clinical Biomarkers
Advertisement

Pancreatic cancer is one of the deadliest forms of the disease, with an average five-year survival rate. Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital and the Pancreatic Cancer Research Team (PCRT), will join hands to find a biomarker for pancreatic cancer.

Advertisement
Finding a cure for pancreatic cancer and other aggressive types of cancers in not the priority of most well established pharmaceutical companies. Instead, large pharmaceutical companies tend to focus their research and development dollars on rare diseases, where profit margins are extremely high and finding a cure for cancer is really tough.

Berg's first drug, BPM 31510, reprograms the metabolism of the cancer cells, re-teaching them to undergo apoptosis, or cell death. The cancer cells die off naturally, without the need for harmful and expensive chemotherapy.

The company has plans to use data and artificial intelligence algorithms, to isolate the root causes of many diseases, including cancer, and develop tailor-made treatment options for patients.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All